Sotera Health Company
NASDAQ:SHC
11.36 (USD) • At close March 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Revenue
| 1,100.441 | 1,049.288 | 1,003.687 | 931.478 | 818.158 | 778.327 | 746.149 |
| Cost of Revenue
| 498.146 | 472.13 | 446.683 | 412.806 | 374.586 | 382.896 | 388.897 |
| Gross Profit
| 602.295 | 577.158 | 557.004 | 518.672 | 443.572 | 395.431 | 357.252 |
| Gross Profit Ratio
| 0.547 | 0.55 | 0.555 | 0.557 | 0.542 | 0.508 | 0.479 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 133.363 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 242.63 | 236.667 | 245.714 | 198.158 | 178.525 | 147.48 | 133.363 |
| Other Expenses
| 62.039 | 63.799 | 62.94 | 63.781 | 59.029 | 58.562 | 3.866 |
| Operating Expenses
| 304.669 | 300.466 | 308.654 | 261.939 | 237.554 | 206.042 | 191.338 |
| Operating Income
| 297.626 | 276.692 | 248.35 | 256.733 | 206.018 | 183.597 | 80.847 |
| Operating Income Ratio
| 0.27 | 0.264 | 0.247 | 0.276 | 0.252 | 0.236 | 0.108 |
| Total Other Income Expenses Net
| -183.752 | -170.665 | -491.461 | -81.017 | -244.878 | -184.513 | -56.625 |
| Income Before Tax
| 113.874 | 106.027 | -243.111 | 175.716 | -38.86 | -0.916 | 24.222 |
| Income Before Tax Ratio
| 0.103 | 0.101 | -0.242 | 0.189 | -0.047 | -0.001 | 0.032 |
| Income Tax Expense
| 69.476 | 54.651 | -9.541 | 58.595 | -1.369 | 19.509 | 30.098 |
| Net Income
| 44.398 | 51.376 | -233.57 | 116.882 | -37.491 | -20.425 | -5.87 |
| Net Income Ratio
| 0.04 | 0.049 | -0.233 | 0.125 | -0.046 | -0.026 | -0.008 |
| EPS
| 0.16 | 0.18 | -0.83 | 0.41 | -0.13 | -0.072 | -0.024 |
| EPS Diluted
| 0.16 | 0.18 | -0.83 | 0.41 | -0.13 | -0.072 | -0.024 |
| EBITDA
| 442.202 | 420.199 | -2.993 | 404.247 | 319.962 | 305.248 | 316.596 |
| EBITDA Ratio
| 0.402 | 0.4 | 0.317 | 0.36 | 0.335 | 0.441 | 0.424 |